PathMaker Neurosystems is a pioneering brand that is revolutionizing the treatment of serious neurological disorders. Leveraging recent advancements in multi-site neuromodulation, we offer safe and non-invasive solutions for patients with Spasticity and ALS. Our proprietary technology, developed based on the groundbreaking work of Prof.

Zaghloul Ahmed (CUNY) and our esteemed scientific advisors, has the potential to transform lives. With offices in Boston, New York, and Paris, our experienced team of medical device executives is swiftly advancing our clinical-stage programs towards commercialization. Our product pipeline includes the MyoRegulator PM-2200 and MyoRegulator ALS, offering therapeutic indications for various neurological conditions.

At PathMaker Neurosystems, we are committed to pushing the boundaries of neurology and improving patient outcomes. Join us in our mission to make a significant impact in the field of neurological treatment